Follow
Nathaniel W. Mabe
Nathaniel W. Mabe
Dana-Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer
NW Mabe, DB Fox, R Lupo, AE Decker, SN Phelps, JW Thompson, ...
The Journal of clinical investigation 128 (10), 4413-4428, 2018
482018
RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence
CC Lin, NW Mabe, YT Lin, WH Yang, X Tang, L Hong, T Sun, J Force, ...
Cell Death & Differentiation 27 (7), 2234-2247, 2020
402020
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
NW Mabe, M Huang, GN Dalton, G Alexe, DA Schaefer, AC Geraghty, ...
Nature cancer 3 (8), 976-993, 2022
332022
Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence
A Walens, J Lin, JS Damrauer, B McKinney, R Lupo, R Newcomb, DB Fox, ...
Nature communications 11 (1), 5017, 2020
322020
G9a promotes breast cancer recurrence through repression of a pro-inflammatory program
NW Mabe, NMG Garcia, SE Wolery, R Newcomb, RC Meingasner, ...
Cell reports 33 (5), 2020
242020
Regulator of G protein signaling 6 protects the heart from ischemic injury
BR Rorabaugh, B Chakravarti, NW Mabe, SL Seeley, AD Bui, J Yang, ...
Journal of Pharmacology and Experimental Therapeutics 360 (3), 409-416, 2017
202017
i2-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart
RE Waterson, CG Thompson, NW Mabe, K Kaur, JN Talbot, RR Neubig, ...
Cardiovascular research 91 (1), 45-52, 2011
202011
Foxo-dependent Par-4 upregulation prevents long-term survival of residual cells following PI3K–Akt inhibition
JS Damrauer, SN Phelps, K Amuchastegui, R Lupo, NW Mabe, A Walens, ...
Molecular Cancer Research 16 (4), 599-609, 2018
192018
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
DY Lu, JM Ellegast, KN Ross, CF Malone, S Lin, NW Mabe, NV Dharia, ...
Nature Cell Biology 25 (2), 285-297, 2023
142023
Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder
BR Rorabaugh, NW Mabe, SL Seeley, TS Stoops, KE Mucher, CP Ney, ...
Stress 23 (2), 125-135, 2020
132020
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
J So, NW Mabe, B Englinger, KH Chow, SM Moyer, S Yerrum, MC Trissal, ...
JCI insight 7 (19), 2022
112022
VRK1 is required in VRK2-methylated cancers of the nervous system
J So, NW Mabe, B Englinger, SM Moyer, MC Trissal, JG Marques, J Kwon, ...
bioRxiv, 2021.12. 28.474386, 2021
22021
Regulator of G protein signaling protein 6 (RGS6) protects the heart from ischemic injury
B Rorabaugh, N Mabe, S Seeley, A Bui, J Yang, R Neubig, R Fisher
The FASEB Journal 29, 1026.8, 2015
12015
244 Targeting gangliosides in pediatric cancer
GN Dalton, WJ Kim, NW Mabe, M Huang, MC Rotiroti, AM Tousley, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Abstract PR003: Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma
NW Mabe, M Huang, DA Schaefer, GN Dalton, G Digiovanni, G Alexe, ...
Cancer Research 82 (23_Supplement_2), PR003-PR003, 2022
2022
Synthetic lethality of VRK1 in VRK2-methylated cancers
J So, N Mabe, B Englinger, J Kwon, B Shim, M Filbin, K Stegmaier, ...
Cancer Research 82 (12_Supplement), 2147-2147, 2022
2022
Identification of ADRN-specific, MES-specific, and pan-subtype therapeutic targets in neuroblastoma
NM Kendsersky, NW Mabe, A Farrel, LD Grossmann, M Odrobina, ...
Cancer Research 82 (12_Supplement), 3889-3889, 2022
2022
Adaptation and Selection Shape Clonal Evolution During Residual Disease and Recurrence
A Walens, J Lin, JS Damrauer, R Lupo, R Newcomb, DB Fox, NW Mabe, ...
bioRxiv, 2020.04. 22.055780, 2020
2020
Endothelial to Mesenchymal Transition in the Rat Heart Following Exposure to a Model of Posttraumatic Stress Disorder
BR Rorabaugh, NW Mabe, TS Stoops, SL Seeley, KE Mulcher, CP Ney, ...
The FASEB Journal 33 (S1), 831.6-831.6, 2019
2019
Defining and Targeting Epigenetic Rewiring During Tumor Progression
NW Mabe
Duke University, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20